LB Pharmaceuticals
LBRX39.8302.13% ( +0.830 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: LB Pharmaceuticals(LBRX) predict that the EBIT is -22.1 M (--%), Beat estimate;the EPS is -0.67 (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.02B--
-0.02B--
+0.00B--%
EPSExceed expectations
-0.67--
-0.745--
+0.0750--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf